Sleep disturbance associated with Smith-Magenis syndrome.
10.3760/cma.j.cn511374-20200926-00698
- Author:
Miaomiao PAN
1
;
Li CHEN
Author Information
1. School of Basic Medical Sciences, Fudan University, Shanghai 200032, China. chenli2008@fudan.edu.cn.
- Publication Type:Journal Article
- MeSH:
Animals;
Circadian Rhythm;
Humans;
Melatonin;
Mice;
Sleep;
Sleep Wake Disorders/genetics*;
Smith-Magenis Syndrome/genetics*
- From:
Chinese Journal of Medical Genetics
2021;38(12):1262-1265
- CountryChina
- Language:Chinese
-
Abstract:
Smith-Magenis syndrome (SMS) (OMIM #182290) is a rare genetic disorder with a prevalence of 1 in 25 000 live births. Approximately 90% of SMS patients have harbored a 3.7 Mb interstitial 17p11.2 deletion involving the RAI1 gene, while 10% of cases have carried pathogenic variants of the RAI1 gene. SMS is characterized by sleep disturbance, intellectual impairment, developmental delay, craniofacial and cardiovascular anomalies, obesity, self injury, aggressive and autistic-like behaviors. Most SMS patients have sleep disorders such as short total sleep time, frequent night waking, short sleep onset, and early morning waking. The sleep disturbance may aggravate with age and persist throughout life. Three mechanisms have been delineated. The first concern was the abnormal secretion of melatonin, with high levels during daytime and low levels at night. Evaluation of the integrity of the intrinsically photosensitive retinal ganglion cell (ipRGC)/melanopsin system has found that SMS patients showed dysfunction in the sustained component of the pupillary light responses to blue light. Synchronization of daily melatonin profile and its photoinhibition are dependent on the activation of melanopsin. Dysfunction of the retina-melanin system may be one of the causes of melatonin spectrum disorders. Secondly, dysregulation of circadian rhythm gene expression has also been noted in mice and SMS patients. Finally, there may be association between sleep deprivation symptoms and DNA methylation patterns, which has provided new insights for SMS-associated sleep disorders and symptoms alike. Treatment for SMS-related sleep disorders is administered primarily through medications like melatonin tablets, which can alleviate insomnia-related sleep difficulties, in particular externalizing behavior in children. Researchers are also actively exploring other treatments for SMS currently.
